SYNTHESIS, CHARACTERIZATION AND ANTIOXIDANT ACTIVITY OF SOME NEW THIAZOLIDIN-4-ONE DERIVATIVES

Authors

  • Maria APOTROSOAEI University of Medicine and Pharmacy„Grigore T. Popa”- Iasi
  • Ioana Vasincu (GEANGALAU) University of Medicine and Pharmacy„Grigore T. Popa”- Iasi
  • Sandra CONSTANTIN University of Medicine and Pharmacy„Grigore T. Popa”- Iasi
  • F. BURON University of Orléans
  • S. ROUTIER University of Orléans
  • Lenuta PROFIRE University of Medicine and Pharmacy„Grigore T. Popa”- Iasi

Abstract

Aim: To design new thiazolidin-4-ones derivatives and to evaluate their potential antioxidant effects using in vitro methods. Material and methods: New ethyl esters of the 2-(R-phenyl)-4-oxo-thiazolidin-3-yl propionic acid were synthesized using “one step reaction” between different aromatic aldehydes, thioglycolic acid and beta-alanine ethyl ester hydrochloride. The antioxidant potential of the synthesized compounds was evaluated using the DPPH radical scavenging assay and phosphomolybdenum method. Results: Eight thiazolidine-4-one derivatives were obtained in good yields and high purity. The structure of the synthesized compounds was confirmed using IR spectroscopy. The evaluation of antioxidant activity showed that 2-[(4-NO2)-phenyl]-4-oxo-thiazolidin-3-yl propionic acid ethyl ester (compound 16) was the most active compound. For this derivative the DPPH radical scavenger activity (I% = 91.63%±0.77) and the total antioxidant capacity (absorbance = 1.0691±0.0763) were similar with that of ascorbic acid used as standard antioxidant. Conclusions: The antioxidant activity of the thiazolidine-4-one derivatives depends on the nature of the phenyl ring substituents, the NO2 and OH radicals having the most significant influence.

Author Biographies

  • Maria APOTROSOAEI, University of Medicine and Pharmacy„Grigore T. Popa”- Iasi

    Faculty of Pharmacy
    Ph.D. student

  • Ioana Vasincu (GEANGALAU), University of Medicine and Pharmacy„Grigore T. Popa”- Iasi

    Faculty of Pharmacy
    Discipline of Pharmaceutical Chemistry

  • Sandra CONSTANTIN, University of Medicine and Pharmacy„Grigore T. Popa”- Iasi

    Faculty of Pharmacy
    Discipline of Pharmaceutical Chemistry

  • F. BURON, University of Orléans

    Institute of Organic and Analytical Chemistry – Orléans, France

  • S. ROUTIER, University of Orléans

    Institute of Organic and Analytical Chemistry – Orléans, France

  • Lenuta PROFIRE, University of Medicine and Pharmacy„Grigore T. Popa”- Iasi

    Faculty of Pharmacy
    Discipline of Pharmaceutical Chemistry

References

1. Barreca M, Balzarini J, Chimirri A et al. Design, synthesis, structure-activity relationships, and mo-lecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents. J Med Chem 2002; 45(24): 5410-5413
2. Chen H, Bai J, Jiao L, Guo Z, Yin Q, Li X. Design, microwave-assisted synthesis and HIV-RT inhibi-tory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones. Bioorg Med Chem 2009; 17 (11): 3980-3986.
3. Shelke S, Mhaske P, Nandave M, Narkhade S, Walhekar N. Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl)thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents. Bioorg Med Chem Lett 2012; 22: 6373-6376.
4. Kunzler A, das Neves A, Pereira C et al. Synthesis, antifungal and cytotoxic activities of 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidinones. Eur J Med Chem 2013; 64: 74-80.
5. Myangar K, Akhaja T, Naik D, Raval J. Thiazolidinyl-quinazolin-4-one derivatives: Design, Synthesis and In vitro evaluation of Antitubercular activities. Chem Biol Interface 2012; 2(3): 157-171.
6. El Nezhawy A, Ramla M, Khalifa N, Abdulla M. Synthesis and antioxidant activity of some thiazolidin-4-one derivatives. Monatsh Chem 2009; 140: 531-539.
7. Isloor A, Sunil D, Shetty P, Malladi S, Pai K, Maliyakkl N. Synthesis, characterization, anticancer, antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells. Med Chem Res 2013; 22: 758-767.
8. Apostolidis I, Liaras K, Geronikaki A et al. Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents. Bioorg Med Chem 2013; 21(2): 532-539.
9. Sala M, Chimento A, Saturnino C et al. Synthesis and cytotoxic activity evaluation of 2,-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorg Med Chem Lett 2013; 23: 4990-4995.
10. Gududuru V, Hurh E, Dalton J, Miller D. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Bioorg Med Chem Lett 2004; 14(21): 5289-5293.
11. Gospodaryov D, Lushchak V. Oxidative Stress: Cause and Consequence of Diseases, In: Oxidative Stress and Diseases, Croatia: In Tech 2012, ISBN: 978-953-51-0552-7. Available from: http://www.intechopen.com/books/oxidative-stress-and-diseases/oxidative-stress-as-a-causeand-consequence-of-diseases.
12. Holmes CP, Chinn JP, Loook GC, Gordon EM, Gallop MA. Strategies for combinatorial organic synthesis: solution and polymer-supported synthesis of 4-thiazolidinones and 4-methathiazanones de-rived from amino-acids. J Org Chem 1995; 60(22): 7328-7333.
13. Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of phosphomolybdenum complex: Specific application to the determination of vitamin E1. Anal Biochem 1999; 269: 337-341.

Additional Files

Published

2018-05-17